KPTN
protein-codingkaptin, actin binding protein, the group of KICSTOR complex
Gene summary
This gene encodes a filamentous-actin-associated protein, which is involved in actin dynamics and plays an important role in neuromorphogenesis. This protein is part of the KICSTOR protein complex that localizes to lysosomes. Mutations in this gene result in an autosomal recessive form of intellectual disability. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~9.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0100038
Submitter: ClinGen
*KPTN* encodes a component of the mTOR regulatory complex KICSTOR. *KPTN* was first reported in relation to autosomal recessive complex neurodevelopmental disorder in 2014 (Baple et al., PMID: 24239382). The disorder is characterized by global developmental delay, intellectual disability, hypotonia, macrocephaly with frontal bossing, and facial dysmorphic features. Additionally, more variable features can include seizures, anxiety, and autistic features. Six variants (2 frameshift, 2 splice, 1 nonsense, and 1 inframe insertion) that have been reported in 9 probands in 6 publications (PMIDs: 24239382, 25847626, 31999056, 32358097, 32808430, 36703628) are included in this curation. Variants in this gene segregated with disease in 11 additional family members. Nine affected individuals belong to 4 nuclear families from a single extended Amish pedigree; all are homozygous or compound heterozygous for two founder variants (p.Ser259* and p.Met241_Gln246dup) (PMID: 24239382). More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is known to be loss of function. This gene-disease relationship is also supported by functional alterations in non-patient cells, and a *Kptn* null mouse model that exhibits cognitive deficits, macrocephaly, and increased mTOR signalling (PMID: 37437211). In summary, there is definitive evidence supporting the relationship between *KPTN* and autosomal recessive complex neurodevelopmental disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on July 16, 2025 (SOP Version 11).
Inheritance Pattern: AR
Disease ID:MONDO:0014289
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014289
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014289
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014289
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KPTN variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_007059.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 37 | 3 | 42 | ||
| missense | 3 | 102 | 10 | 115 | ||
| nonsense | 2 | 4 | 1 | 7 | ||
| start loss | 0 | |||||
| frameshift | 7 | 4 | 3 | 14 | ||
| splice donor/acceptor (+/-2bp) | 4 | 5 | 4 | 13 | ||
| Total | 13 | 16 | 112 | 47 | 3 | 191 |
Highest pathogenic variant AF is 0.0006136163
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_008990.2 | 12 | MANE Select | |
| Ensembl | ENSP00000337850.2 | 12 | MANE Select | |
| RefSeq | NP_001278225.1 | 10 | Standard | |
| Ensembl | ENSP00000470364.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- actin filament organization
- cellular response to amino acid starvation
- cellular response to glucose starvation
- protein localization to lysosome
- negative regulation of TORC1 signaling
Molecular Function
- actin filament binding
Cellular Component
- lysosomal membrane
- lamellipodium
- filamentous actin
- stereocilium
- postsynaptic actin cytoskeleton
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000338134
- Coding exons
- 12
- Length
- 9125
- Individuals with no LoFs
- 124726
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 84
- Defined
- 124810
- p
- 0.000337
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.45 | 200 | 266 | 0.751 | 0.0000154 | 2776 |
| Missense (PolyPhen) | 68 | 90.477 | 0.75157 | 1016 | ||
| Synonymous | 0.829 | 106 | 117 | 0.903 | 0.00000703 | 902 |
| Loss of Function | 2.28 | 12 | 24.0 | 0.499 | 0.00000122 | 248 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00034 | 0.00032 | rare |
| Latino/Admixed American | 0.00023 | 0.00023 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00031 | 0.00028 | rare |
| Finnish | 0.000093 | 0.000093 | rare |
| European (Non-Finnish) | 0.00052 | 0.00052 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: As part of the KICSTOR complex functions in the amino acid-sensing branch of the TORC1 signaling pathway. Recruits, in an amino acid-independent manner, the GATOR1 complex to the lysosomal membranes and allows its interaction with GATOR2 and the RAG GTPases. Functions upstream of the RAG GTPases and is required to negatively regulate mTORC1 signaling in absence of amino acids. In absence of the KICSTOR complex mTORC1 is constitutively localized to the lysosome and activated. The KICSTOR complex is also probably involved in the regulation of mTORC1 by glucose. {ECO:0000269|PubMed:28199306}.;
- Disease
- DISEASE: Mental retardation, autosomal recessive 41 (MRT41) [MIM:615637]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT41 most consistent features are global developmental delay, macrocephaly with frontal bossing, high levels of anxiety, and some features suggestive of a pervasive developmental disorder. Less common features include fifth finger clinodactyly, recurrent pneumonia, and hepatosplenomegaly. {ECO:0000269|PubMed:24239382}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- LoFtool
- 0.441
- RVIS EVS
- -0.47
- RVIS percentile EVS
- 23.43
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.966
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |